Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells

Molecular Nutrition and Food Research

Volumn 54, Issue 12, 2010, Pages 1781-1790

  Ou, Ting Tsz ^a   Wang, Chau Jong ^a   Lee, Yung Shu ^b   Wu, Cheng Hsun ^c   Lee, Huei Jane ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Mackay Memorial Hospital Taitung Branch   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cell cycle; Checkpoint kinase 2; G2 M phase; Gallic acid; Human bladder transitional carcinoma

Indexed keywords

CDC25C PROTEIN, HUMAN; CHECKPOINT KINASE 2; CYCLIN B1; CYCLIN DEPENDENT KINASE; GALLIC ACID; PROTEIN 14 3 3; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANALYSIS OF VARIANCE; ARTICLE; BLADDER TUMOR; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIVISION; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

14-3-3 PROTEINS; ANALYSIS OF VARIANCE; CDC25 PHOSPHATASES; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CYCLIN B1; CYCLIN-DEPENDENT KINASES; G2 PHASE; GALLIC ACID; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; URINARY BLADDER NEOPLASMS;

ATAXIA TELANGIECTASIA;

EID: 78649836711     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000096     Document Type: Article

References (48)

1. Yeh, C. T., Yen, G. C., Effect of vegetables on human phenolsulfotransferases in relation to their antioxidant activity and total phenolics. Free Radic. Res. 2005, 39, 893-904.
2. De Beer, D., Joubert, E., Gelderblom, W. C., Manley, M., Antioxidant activity of South African red and white cultivar wines: free radical scavenging. J. Agric. Food Chem. 2003, 51, 902-909.
3. Bachrach, U., Wang, Y. C., Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Amino Acids 2002, 22, 1-13.
4. Kroes, B. H., van den Berg, A. J., Quarles van Ufford, H. C., van Dijk, H., Labadie, R. P., Anti-inflammatory activity of gallic acid. Planta Med. 1992, 58, 499-504.
5. Galati, G., O'Brien, P. J., Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37, 287-303.
6. Li, L., Ng, T. B., Gao, W., Li, W. et al., Antioxidant activity of gallic acid from rose flowers in senescence accelerated mice. Life Sci. 2005, 77, 230-240.
7. Raina, K., Rajamanickam, S., Deep, G., Singh, M., et al., Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol. Cancer Ther. 2008, 7, 1258-1267.
8. Madlener, S., Illmer, C., Horvath, Z., Saiko, P. et al., Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett. 2007, 245, 156-162.
9. Kawada, M., Ohno, Y., Ri, Y., Ikoma, T. et al., Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 2001, 12, 847-852.
10. Locatelli, C., Leal, P. C., Yunes, R. A., Nunes, R. J., Creczynski-Pasa, T. B., Gallic acid ester derivatives induce apoptosis and cell adhesion inhibition in melanoma cells: the relationship between free radical generation, glutathione depletion and cell death. Chem. Biol. Interact. 2009, 181, 175-184.
11. Agarwal, C., Tyagi, A., Agarwal, R., Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol. Cancer Ther. 2006, 5, 3294-3302.
12. Veluri, R., Singh, R. P., Liu, Z., Thompson, J. A., Agarwal, R., Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis 2006, 27, 1445-1453.
13. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
14. Shen, Z., Shen, T., Wientjes, M. G., O'Donnell, M. A., Au, J. L., Intravesical treatments of bladder cancer: review. Pharm. Res. 2008, 25, 1500-1510.
15. Doherty, S. C., McKeown, S. R., McKelvey-Martin, V., Downes, C. S. et al., Cell cycle checkpoint function in bladder cancer. J. Natl. Cancer Inst. 2003, 95, 1859-1868.
16. Owa, T., Yoshino, H., Yoshimatsu, K., Nagasu, T., Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr. Med. Chem. 2001, 8, 1487-1503.
17. Agarwal, C., Singh, R. P., Dhanalakshmi, S., Tyagi, A. K. et al., Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003, 22, 8271-8282.
18. Taylor, W. R., Stark, G. R., Regulation of the G2/M transition by p53. Oncogene 2001, 20, 1803-1815.
19. Sebastian, B., Kakizuka, A., Hunter, T., Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA 1993, 90, 3521-3524.
20. Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem. 2004, 279, 25813-25822.
21. Ou, T. T., Wang, C. J., Hung, G. U., Wu, C. H., Lee, H. J., Aqueous extract of Shi-Liu-Wei-Liu-Qi-Yin induces G2/M phase arrest and apoptosis in human bladder carcinoma cells via Fas and mitochondrial pathway, eCAM. 2009, Doi: 10.1093/ecam/nep016.
22. Yeh, M. Y., Yu, D. S., Chen, S. C., Lin, M. S. et al., Establishment and characterization of a human urinary bladder carcinoma cell line (TSGH-8301). J. Surg. Oncol. 1988, 37, 177-184.
23. Molinari, M., Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000, 33, 261-274.
24. Agarwal, R., Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 2000, 60, 1051-1059.
25. Singh, R. P., Agarwal, R., Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer 2006, 13, 751-778.
26. Matsuoka, S., Huang, M., Elledge, S. J., Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282, 1893-1897.
27. Peng, C. Y., Graves, P. R., Ogg, S., Thoma, R. S., Byrnes, M. J., 3rd, C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 1998, 9, 197-208.
28. Liu, Q., Guntuku, S., Cui, X. S., Matsuoka, S., Cortez, D., Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000, 14, 1448-1459.
29. Melchionna, R., Chen, X. B., Blasina, A., McGowan, C. H., Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol. 2000, 2, 762-765.
30. Shiloh, Y., ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3, 155-168.
31. Khanna, K. K., Lavin, M. F., Jackson, S. P., Mulhern, T. D., ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 2001, 8, 1052-1065.
32. Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., Chen, D. J., ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276, 42462-42467.
33. Sakagami, H., Kuribayashi, N., Iida, M., Sakagami, T., Takeda, M., Induction of DNA fragmentation by tannin- and lignin-related substances. Anticancer Res. 1995, 15, 2121-2128.
34. Yang, G. Y., Liao, J., Kim, K., Yurkow, E. J., Yang, C. S., Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998, 19, 611-616.
35. Hillman, G. G., Forman, J. D., Kucuk, O., Yudelev, M., Maughan, R. L., Genistein potentiates the radiation effect on prostate carcinoma cells. Clin. Cancer Res. 2001, 7, 382-390.
36. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
37. Hartwell, L. H., Kastan, M. B., Cell cycle control and cancer. Science 1994, 266, 1821-1828.
38. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366, 701-704.
39. Yim, D., Singh, R. P., Agarwal, C., Lee, S., Chi, H., A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005, 65, 1035-1044.
40. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8, 9-22.
41. Singh, R. P., Dhanalakshmi, S., Agarwal, R., Phytochemicals as cell cycle modulators - a less toxic approach in halting human cancers. Cell Cycle 2002, 1, 156-161.
42. Turowski, P., Franckhauser, C., Morris, M. C., Vaglio, P., Fernandez, A., Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells. Mol. Biol. Cell 2003, 14, 2984-2998.
43. Peng, C. Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277, 1501-1505.
44. Margolis, S. S., Perry, J. A., Forester, C. M., Nutt, L. K., Guo, Y., Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 2006, 127, 759-773.
45. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277, 1497-1501.
46. Bartek, J., Lukas, J., Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3, 421-429.
47. Dong, X., Wang, L., Taniguchi, K., Wang, X., Cunningham, J. M., Mutations in CHEK2 associated with prostate cancer risk. Am. J. Hum. Genet. 2003, 72, 270-280.
48. Abraham, R. T., Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15, 2177-2196.